Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1292 of 5804
-
New hope for liver disease: drug shows promise in reducing damage
Disease control OngoingThe purpose of this study is to find out about the safety and how well the study intervention (elafibranor) works in participants with PBC. The participants in this study will have confirmed PBC with inadequate response or intolerance to UDCA, which is a medication used in the ma…
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Heat therapy: a new hope for long COVID sufferers?
Symptom relief Recruiting nowPost-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a commo…
Phase: NA • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Zapping the brain while in VR: a new hope for social skills?
Symptom relief Recruiting nowThe cerebellum is increasingly recognized for its crucial role in high-level cognitive processes, particularly in the domain of social cognition and action prediction. Disruptions in cerebellar circuits can lead to significant impairments in anticipating others' intentions and be…
Phase: NA • Sponsor: I.R.C.C.S. Fondazione Santa Lucia • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New pill shows promise in slowing rare Cancer's growth
Disease control Recruiting nowThe study is a Phase 2 clinical trial of the drug cirtuvivint as a second-line treatment for advanced soft tissue sarcomas. The study is being conducted in Spain and is expected to enroll approximately 25 patients in total. The primary objective of this Phase 2 study is to evalua…
Phase: PHASE2 • Sponsor: Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Viruses vs. superbugs: new hope for skin infections?
Disease control ENROLLING_BY_INVITATIONThis study addresses the increasingly severe global public health challenge of antibiotic resistance, focusing on exploring phage therapy as a potential treatment strategy for multidrug-resistant bacterial skin infections. Bacteriophages, with advantages such as high specificity,…
Phase: EARLY_PHASE1 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a simple pill replace the IV drip for ER infections?
Disease control Recruiting nowPatients admitted to the hospital with acute infections are often treated with intravenous (IV) antibiotics. Around 70% of these infections fall into three categories: respiratory tract infections, urinary tract infections, and cellulitis. A Danish study found that 76% of patient…
Phase: NA • Sponsor: University of Southern Denmark • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New program aims to help smokers with mental illness kick the habit
Disease control Recruiting nowThe smoking rate among people with mental disorders is higher than in the general population. Greater exposure to the harmful effects of tobacco partly explains the major inequality in life expectancy observed among people with mental disorders who, depending on the disorder and …
Phase: NA • Sponsor: GCS-CCOMS • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New combo radiation aims to cut prostate cancer treatment time
Disease control Recruiting nowThis is a phase II study of ultrahypofractionated whole pelvis proton therapy with brachytherapy boost for patients with high risk or unfavorable intermediate risk prostate with elevated risk of lymph node involvement.
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could testosterone therapy be safe for men with prostate cancer? new trial aims to find out
Disease control Recruiting nowThis phase IV trial studies the effects of testosterone replacement therapy (TRT) on treatment outcomes in hypogonadal men with prostate cancer that has not spread to other parts of the body (localized) and who are on active surveillance (AS). AS in prostate cancer involves close…
Phase: PHASE4 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Gut bacteria transplant could tame Crohn's inflammation
Disease control Recruiting nowCrohn's disease (CD) develops because of a disruption of homeostasis between the gut microbiota and the host immune system resulting in excessive inflammation in the intestinal tract. Current drug therapies for CD are directed at the immune system. The emergence of fecal microbio…
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can targeted therapy ease the mental health toll of stigma in LGBTQ+ people?
Symptom relief Recruiting nowLesbian, gay, bisexual, transgender, and queer+ (LGBTQ+) individuals experience a breadth of mental health disparities. Reducing these disparities is an area of key psychological research. Minority stress is theorized to be an underlying source of the disparities (Meyer, 2003). M…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New blood test could sniff out stomach Cancer's secret return
Knowledge-focused Recruiting nowGastric cancer (GC) is a leading cause of cancer-related death worldwide. Even in patients undergoing curative surgery for non-metastatic disease, postoperative recurrence frequently occurs due to undetected minimal residual disease (MRD). This study aims to establish a highly se…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Cartoon workouts may help seniors beat fear of falling
Symptom relief CompletedImpaired mobility in older adults significantly exacerbates the risk of falls and subsequent injuries. Beyond physical sequelae, fall precipitate psychological burdens, notably the fear of falling and kinesiophobia. This study investigated the efficacy of animation-guided video e…
Phase: NA • Sponsor: Mustafa Kemal University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New study targets colorectal cancer in underrepresented minorities
Disease control Recruiting nowHigh blood pressure (hypertension) is a known side effect of the treatment with fruquintinib. Current research does not provide a clear answer whether minority groups such as Black/African American and/or Hispanic/Latino with refractory metastatic colorectal cancer (mCRC) have a …
Phase: PHASE4 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Experimental cell therapy takes on stubborn brain autoimmune disorders
Disease control Recruiting nowThis study is an open-label, prospective, exploratory clinical trial that includes a dose escalation phase and a dose expansion phase, aimed at evaluating the safety, cell dynamics, and preliminary efficacy of GT719 cells in adult participants with recurrent/refractory antibody-m…
Phase: PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 26, 2026 17:13 UTC
-
Old HIV drug repurposed to flush out hidden virus in new pilot trial
Disease control Recruiting nowAntiretroviral therapy or ART blocks HIV replication reducing plasma viral loads to undetectable levels but has no effect on persistently infected cells in the body, called the virus reservoir. These cells carry infectious HIV capable of restarting HIV replication if therapy is s…
Phase: NA • Sponsor: University of Toronto • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug targets tough cancers with KRAS G12V mutation
Disease control OngoingPhase 1 study to determine the safety, tolerability, and anti-tumor activity of QTX3544 as a single agent or in combination with cetuximab.
Phase: PHASE1 • Sponsor: Quanta Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Exercise program aims to beat fatigue in testicular cancer survivors
Symptom relief Recruiting nowTesticular germ cell tumor (TGCT) is the most common malignancy in men between 15 and 40 years. Although TCGT survivors have a good survival prognosis, they suffer from short- and long-term sequelae such as chronic fatigue, psychological disorders, cardiovascular toxicities and s…
Phase: NA • Sponsor: Centre Leon Berard • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
One-shot gene therapy aims to tame rett syndrome in young girls
Disease control OngoingRett syndrome (RTT) is a serious neurodevelopmental disorder that has a significant impact on patients and their families. Patients suffer from severe social dysfunction and poor quality of life, and there is currently no effective treatment available. The MECP2 functional loss m…
Phase: EARLY_PHASE1 • Sponsor: Guangzhou Women and Children's Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could a simple eye drop stop blindness after retinal detachment?
Prevention Recruiting nowThis study has two main objectives. The first objective is to study the pharmacokinetics of topical netarsudil administration in the posterior segment of the eye, where netarsudil must exert its effect in order to prevent formation of tractional membranes. The second objective i…
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Prevention
Last updated Jun 27, 2026 07:55 UTC